Cardiomyopathy Flashcards
What is DCM?
Impaired ventricular function.
Can be primary, or the end result.
Can affect one or (often) all chambers.
Generally poor prognosis.
What are the signs of DCM?
Thready and irregular pulse (AF), narrow pulse pressure, raised JVP, S3 and S4, MR murmur.
SOB at rest, displaced apex beat, pleural effusions, ascites, hepatomegaly.
Ankle/sacral/pulmonary oedema.
What are the symptoms of DCM?
Progressive and slow onset.
SOB, fatigue, orthopnoea, postnatal depression, ankle swelling, weight gain, cough.
What are the risk factors of DCM?
Genetics, muscular dystrophy, infection, autoimmunity, post-partum, alcohol, trauma.
What are the investigations of DCM?
ECG (LBBB), CXR, bloods (FBC, U&E, NT-proBNP), ECHO, CMRI, cor angio, biopsy.
PMH - systemic illness, travel, hypertension.
SH - alcoholism, occupation.
What is the treatment of DCM?
General - correct anaemia and endocrine disturbance, remove exacerbating drugs, advice of fluid and salt intake, management of weight.
Specific - ACEis, diuretics, BBs, entresto, spironolactone, anticoagulants, sudden cardiac death risk assessment, cardiac transplant.
What is restrictive and infiltrative cardiomyopathy?
Less common. ~50% are related to disorders.
Pathology - the inability to fill a ventricle well, whose wall has reduced compliance.
Non-infiltrative - familial, forms of HCM, diabetic
Infiltrative - amyloid, sarcoid.
Endomyocardial - fibrosis, carcinoid, drugs.
What are the investigations for restrictive and infiltrative cardiomyopathy?
ECG (LBBB), CXR, bloods (FBC, U&E, NT-proBNP), ECHO, CMRI, biopsy (false negative rate), non-cardiac biopsy (amyloid).
Autoantibodies (sclerotic CT diseases).
Fabry (low plasma alpha-galactosidase A activity).
What is the treatment for restrictive and infiltrative cardiomyopathy?
(Specific) - BBs, anticoagulants, sudden cardiac death risk assessment, cardiac transplant, amyloid or Fabry’s for iron overload, ICD.
Limited diuretic use (low filling pressures cause problems), limited ACEi use.
What is HCM?
Impaired relaxation.
Myocyte hypertrophy and disarray.
Generalised or segmental thickness.
Septal hypertrophy can cause mitral valve defects, leading to LVOT obstruction.
Coronary arteries are affected by narrowing and consequent ischaemia, fibrosis and arrhythmias.
What is the prevalence of HCM?
60% - sarcomere gene mutation.
30% - idiopathic.
10% - other.
Prevalence - high (autosomal dominant).
What are the signs, symptoms and investigations of HCM?
Signs - irregular pulse (AF), double impulse over apex, thrills, raised JVP, LVOT murmur (increases with Valsalva, decreases with squatting).
Symptoms - asymptomatic, fatigue, SOB, anginal-like chest pain, exertional pre-syncope, syncope related to arrhythmias.
Investigations - ECG, ECHO, CMRI, ETT.
What is the treatment for HCM?
General - avoid heavy exercise and dehydration, explore family history, consider genetic testing, regular follow ups to assess risks/progress.
Specific - ICD, BBs, verapamil, disopyrimide, anticoagulants (AF), surgical septal ablasion.
What is myocarditis?
Acute or chronic inflammation of the myocardium; can be associated with pericarditis and arrhythmias; can appear as DCM.
The most common cause is viral.
Inflammatory cells infiltrate the myocardium, leading to HF and arrhythmias.
What are the symptoms and investigations of myocarditis?
Symptoms - HF, fatigue, SOB, cerebral palsy, fever.
Investigations - ECG, biomarkers (MI), ECHO, CMRI, biopsy, viral DNA PCR, autoantibodies, strep antibodies, HIV.